Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Gut|August 5, 2011
Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransitionWei Zhu, Mu-Yan Cai, Zhu-Ting Tong, et al.
Oncotarget|July 30, 2014
Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expressionFeng-Wei Wang, Mu-Yan Cai, Shi-Juan Mai, et al.
Gut|June 16, 2011
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
Theranostics|May 4, 2018
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinomaXue-Kang Qi, Hui-Qiong Han, Hao-Jiong Zhang, et al.
Plos Genetics|February 19, 2015
Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsFang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
The Journal of Pathology|January 24, 2013
The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomasDong Qian, Bin Zhang, Li-Ru He, et al.
Plos Genetics|December 8, 2021
Correction: Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple TargetsFang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
Frontiers in Cell and Developmental Biology|November 24, 2022
Impact of WTAP in small HCC and paired adjacent non-neoplastic liver tissue on recurrence: A cohort study with external extension analysisJin-Ling Duan, Min-Hua Deng, Zhi-Cheng Xiang, et al.
Frontiers in Cell and Developmental Biology|August 1, 2022
Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for ImmunotherapyJie Zhou, Run-Cong Nie, Yi-Xin Yin, et al.
Journal of Surgical Oncology|November 30, 2013
Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancerYuan-Hong Gao, Xin An, Wei-Jiang Sun, et al.
Pageof 13